or
forgot password
  • cancer clinical trials in charleston, SC

  • A Multi-center Clinical Trial of the Misago(TM) Self-Expanding Stent System for Superficial Femoral Artery
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Peripheral Vascular Disease
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Roper St. Francis Cancer Center at Roper Hospital
    Charleston, South Carolina 29401
    Kidney Cancer
    Validation of a Multi-gene Test for Lung Cancer Risk
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Lung Cancer
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Liver Transplant Recipient
    Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    End Stage Renal Disease, Renal Transplant
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Carcinoma, Squamous Cell of the Head and Neck
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Roper Hospital
    Charleston, South Carolina 29401
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Medical University of South Carolina, Dept. OB/GYN
    Charleston, South Carolina 29425
    Ovarian Cancer
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia
    Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Bacteremia
    Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Mouth Neoplasms, Head and Neck Neoplasms, Tongue Neoplasms, Carcinoma, Squamous Cell
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Roper Hospital
    Charleston, South Carolina 29401
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Study of PX-866 and Docetaxel in Solid Tumors
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
    MUSC Hollings Cancer Center
    Charleston, South Carolina 29425
    Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma
    Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

    Charleston, South Carolina
    Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male
    A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
    Medical University of SC-Pediatric Sickle Cell Center
    Charleston, South Carolina 29425
    Sickle Cell Disease
    Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Head and Neck Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Medical University of South Carolina Med Univ SC
    Charleston, South Carolina 29425
    Metastatic Renal Cell Carcinoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Roper Hospital
    Charleston, South Carolina 29401
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Multiple Myeloma
    Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
    Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
    Medical University of South Carolina MUSC/HCC (2)
    Charleston, South Carolina 29425
    Acute Myeloid Leukemia (AML)
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Hollings Cancer Center at Medical University of South Carolina

    Trial Locations
    Hollings Cancer Center at Medical University of South Carolina
    Roper St. Francis Cancer Center at Roper Hospital
    Breast Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Charleston Cancer Center
    Charleston, South Carolina 29406
    Chronic Myeloid Leukemia
    Phase 1 and 2 Study of PX-866 and Cetuximab
    MUSC Hollings Cancer Center
    Charleston, South Carolina 29425
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
    Medical University of South Carolina

    Trial Locations
    Medical University of South Carolina
    Charleston Hematology / Oncology
    Breast Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Roper Hospital
    Charleston, South Carolina 29401
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Exercise and Stress Management Post Autologous and Allogeneic Transplant
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Physiological Stress
    Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial

    Charleston, South Carolina
    Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction
    Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients
    Medical University of South Carolina, Division of Transplant
    Charleston, South Carolina 29425
    Kidney Transplantation
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Medical University of South Carolina MUSC
    Charleston, South Carolina 29425
    Non-small Cell Lung Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    Medical University of South Carolina (MUSC)
    Charleston, South Carolina 29425
    Colorectal Cancer Metastatic
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Head and Neck Cancer, Precancerous Condition
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Advanced Prostate Cancer, Prostatic Neoplasms
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Fungal Infection, Leukemia, Neutropenia
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Prostate Cancer
    A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Conventional Chondrosarcoma
    IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Charleston, South Carolina
    Prostate Cancer, Prostatic Neoplasm
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
    Charleston Hematology Oncology Associates, PA
    Charleston, South Carolina 29403
    Multiple Myeloma
    Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
    Research Site
    Charleston, South Carolina
    Cancer, Hematologic Malignancies, Multiple Myeloma, Oncology, Bone Metastases, Multiple Myeloma Bone Lesions